Arbutus Biopharma Statistics
NASDAQ: ABUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.02-0.05 (-1.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Arbutus Biopharma by the numbers
Arbutus Biopharma has a market capitalization of $616.2 million based on 153.29M shares outstanding. Its trailing P/E ratio is 3.6. The stock trades 7.6% below its 50-day average and 10.3% below its 200-day average.
Average daily trading volume is 4.98M shares, or about $20.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABUS valuation vs. peer median
| Metric | ABUS | Peer median | Difference |
|---|---|---|---|
| Market cap | $616.24M | $625.81M | -2% |
| Avg. volume | 4.98M | 1.25M | +297% |
Peer median across 8 companies: JANX, OLMA, KURA, SGMT, ANNX, IMMX, NVCT, APMD.
Valuation
- Market cap
- $616.24M
- P/E (TTM)
- 3.59
- Price / sales (latest FY)
- 43.76
- EPS (TTM)
- $1.12
- Shares outstanding
- 153.29M
Price and trading
- Previous close
- 4.07
- Open
- 4.01
- Day range
- 3.97 – 4.09
- 52-week range
- 3.50 – 5.45
- 52-week change
- -6.73%
- Beta
- —
- Volume
- 2.99M
- Average volume
- 4.98M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 616.24M
- Pe
- 3.59
- Forward Pe
- -24.32
- Eps
- 1.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.45
- Week52 Low
- 3.50
- Avg Volume
- 4.98M
- Shares Outstanding
- 153.29M
- Ma50
- 4.35
- Ma200
- 4.48
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -26.24%
- Pct From52w Low
- 14.86%